SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

Dexcom Inc (NASDAQ:DXCM)

US · Delayed Price · Currency is USD
87.73-1.80 (-2.01%)
 
Market Cap33.11B+28.6%
Revenue (ttm)4.97B+15.5%
Net Income999.70M+74.9%
EPS2.53+75.7%
Shares Out377.36M
PE Ratio33.87
Forward PE28.12
Dividendn/a
Ex-Dividend Daten/a
Volume3,624,407
Open89.50
Previous Close89.53
Day's Range87.36 - 90.05
52-Week Range54.11 - 92.59
Beta1.42
AnalystsBuy
Price Target90.36(+3.00%)
Earnings DateOct 29, 2026
Insider Score
/ 100
DXCM Insider Score

DEXCOM INC has a live Insider Score.

Scored on 0 qualifying trades from 0 insiders in the last 90 days.

Unlock the score

About DXCM

DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.

Address
6340 Sequence Drive, San Diego, CA, 92121, US
Market Cap
33.11 billion
Employees
11,050
Industrial Classification
Medical - Devices

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$3.21M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
-2.01%
5 Days
-0.11%
1 Month
-4.99%
6 Months
+33.05%
1 Year
+28.64%

$DXCM stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.

→ All Stock Lists

Congress Trading

Recent trades of DXCM by members of U.S. Congress

PoliticianTypeTraded
John BoozmanSenate / RPurchase$1.00K – $15.00KJan 26, 2026
Kevin HernHouse / RSale$50.00K – $100.00KDec 31, 2024
Kevin HernHouse / RSale$50.00K – $100.00KDec 30, 2024
Kevin HernHouse / RPurchase$100.00K – $250.00KJul 1, 2021
Kevin HernHouse / RPurchase$100.00K – $250.00KJun 30, 2021
Thomas SuozziHouse / DSale$15.00K – $50.00KJun 3, 2021
Gilbert Ray CisnerosHouse / DSale$1.00K – $15.00KDec 22, 2020
Gilbert Ray CisnerosHouse / DSale$1.00K – $15.00KDec 21, 2020

Recently reported changes in DXCM holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by DXCM's directors and management

Net Shares Purchased by Insiders−40k−20k02025Q32025Q42026Q12026Q22026Q3

Source: SEC EDGAR (Form 4)

Corporate Lobbying

DXCM Estimated quarterly lobbying spending

Source: U.S. Senate LDA

DXCM Revenue by Segment or Geography

DXCM's latest filing doesn't break out revenue by segment.

As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New DXCM patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to DXCM from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in DXCM

ETFEst. Holding Size
VTIVanguard Morningstar Total Stock Market ETF$1.12B
VOOVanguard S&P 500 ETF$933.60M
VOVanguard Morningstar Mid-Cap ETF$760.04M
QQQInvesco QQQ Trust, Series 1$697.63M
VUGVanguard Morningstar Growth ETF$446.59M
IVViShares Core S&P 500 ETF$431.39M

Estimated from each fund’s disclosed top holdings × AUM

DXCM Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

Members only

The live Insider Score for DXCM is included with Insider Access.

Unlock Insider Score

Bull Case vs Bear Case

AI-generated from DXCM’s recent data — informational, not investment advice

Generating analysis…

Insider Score

Our 0–100 Insider Score and the signals behind it.

Members only

The live Insider Score and its full factor breakdown are included with Insider Access.

Unlock Insider Score

Recent Insider Activity

Buys
0
Sells
8
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
Company Directory & Stock Ticker Database | InsiderBuying.com